The colon and rectum are parts of the digestive system, and make up the large [...]Dalantercept- Inlyta Shows Promise for Renal Cell Cancer
The combination of Inlyta (axitinib) and dalantercept, an activin receptor–like kinase 1 (ALK1) signaling inhibitor [...]Rare Disease Day- Join the Conversation
February 28th is designated as Rare Disease Day. Managing a rare cancer diagnosis presents unique challenges. [...]Chemo-brain Among Women with Breast Cancer is Very Common
The largest study to date of a condition known as “chemo-brain” shows that women with [...]Year In Review 2016 MPN
Individuals dealing with myeloproliferative neoplasms (MPNs), including polycythemia vera (PV), essential thrombocythemia (ET) and myelofibrosis, [...]
By Kari Bohlke, ScD Cancer. The word has taken on a meaning that extends beyond [...]Lung Cancer Treatment Gets Personal
Recent advances highlight the power of precision medicine. By Charles H. Weaver, MD Recently, there [...]Defying Age… And Cancer?
Certain new anti-aging skin treatments may have cancer prevention benefits. By Heather Stringer At 45 [...]Myeloproliferative Neoplasms
Cancer Connect MPN Community Cancer Connect MPNCommunity provides current, comprehensive, reliable information on PV, ET, and [...]Metastatic Breast Cancer: Progress and Hope
By Jennifer Murar-Maxon, RN, BSN As cancer treatment enters a new era of personalized medicine, [...]Cancer Genomic Testing is Revolutionizing Personalized Cancer Care
You’ve probably heard of genetic testing for cancer susceptibility, but the more recent and broader [...]Why A Second Opinion is Important after a Diagnosis of Cancer?
A second opinion is an important part of becoming educated about your cancer and your [...]